Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fenglan Pu"'
Autor:
Fenglan Pu, Tianli Li, Chen Shen, Yingqiao Wang, Chunmei Tang, Xiaowen Zhang, Lijiao Yan, Qihe Xu, Jianping Liu
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Background To evaluate the efficacy, effectiveness and safety of fermented Ophiocordyceps sinensis mycelium (FOSM) products for preventing contrast-associated acute kidney injury (CA-AKI).Methods Randomized controlled trials were searched from four C
Externí odkaz:
https://doaj.org/article/60db5af0d2004ec7b351179d24d78101
Autor:
Jiasai Fan, Tianli Li, Fenglan Pu, Nan Guo, Jing Wang, Yuqian Gao, Hongbing Zhao, Xian Wang, Haiyan Zhu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Background: Chinese patent medicines (CMPs) have curative effectiveness in preventing coronary restenosis. However, the relative efficacy between different CPMs has not been sufficiently investigated.Methods: Randomized clinical trials were searched
Externí odkaz:
https://doaj.org/article/afb257b3584b4e86838b9b2024d258ff
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: Myocardial ischemia-reperfusion (I/R) injury is a complex clinical problem that often leads to further myocardial injury. Curcumin is the main component of turmeric, which has been proved to have many cardioprotective effects. However, the
Externí odkaz:
https://doaj.org/article/f4557d289b34492a95310ee60eb8ed65
Autor:
Chen Shen, Jing Li, Yajun Lian, Huidi Lan, Fenglan Pu, Wenjing Zhang, Lingyao Kong, Jianping Liu
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 8, Iss 4, Pp 291-301 (2021)
Objective: To evaluate the effectiveness and safety of Chinese herbal medicines (CHMs) for incomplete immune reconstruction in patients with HIV/AIDS. Methods: Eight electronic databases were searched for randomized controlled trials (RCTs) on the us
Externí odkaz:
https://doaj.org/article/c760971f6c1847928d017a6df01686ce
Autor:
Fenglan Pu
Review question / Objective: To systematically evaluate the efficacy and safety of cordyceps preparations as a complementary preventive therapy for Contrast-induced nephropathy (CIN). Condition being studied: At present, contrast agents are widely us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01483c76465de06057f2a445287f876d
https://doi.org/10.37766/inplasy2022.6.0098
https://doi.org/10.37766/inplasy2022.6.0098
